Oncology / Haematology

A randomized phase II trial evaluating the efficacy of a nivolumab monotherapy lead in or commencement of nivolumab with paclitaxel and carboplatin as neo-adjuvant therapy in early stage triple negative breast cancers

Trial Name: NEO-N  PI: Dr Zee Wan Wong

Who can take part:

  • Patients with previously untreated non-metastatic (M0) TNBC meeting Stage I or II criteria

Exclusion criteria:

  • Confirmed presence of anatomic Stage 3 or 4 disease.
  • Tumour of any size considered inoperable at presentation
  • Multifocal or bilateral invasive breast cancer

For further information please contact Judi Clarke – 03 9784 8301

Trial Phase

Non-drug Phase 1 Phase 2 Phase 3 Phase 4